VIC Tech 2025 Annual Report: Executive Summary
2025 was a highly productive year for VIC and our portfolio companies. Click Here to download the Annual Report Executive Summary or view it below.
A Letter from our CEO
As we begin a new year, I want to take a moment to reflect on where VIC Technology Venture Development stands today and where we believe we are headed. The past year reinforced something we have long believed: building...
New Weight Loss Pill Targets Fat Storage, Not Appetite Suppression, Promising Healthy Fat Loss Without Muscle Decline
VIC Tech, a leading builder of high-impact, innovative life science companies, today unveiled icosiMED, a venture-backed biotech developing what could become the first oral medication that decreases fat while building...
Zebra Analytix Announces Upcoming Launch of ScentZ GC
Zebra Analytix, a leader in advanced chemical analysis technologies, today announced the upcoming launch of its ScentZ GC compact Gas Chromatograph.
VIC Fellows Spotlight: Olivia Asfaha, PhD
The VIC Fellows Program offers experienced professionals the opportunity to learn how to identify and evaluate high-potential innovations from around the world. We’re proud to showcase the members of the 2025–2026...
VIC Tech Expands Strategic Advisory Board with Addition of Global Business Leader Rajeev Nair
VIC Tech is pleased to announce the appointment of Rajeev Nair, a seasoned global business executive with nearly three decades of experience scaling and transforming multinational organizations, to its Strategic...
Market Access for IVD Tests in Europe: England, France, Germany, Italy, and Spain
Introduction VIC Technology Venture Development is pleased to introduce the second installment in a new educational series on international market access for IVD tests. This White Paper developed by our strategic...
Fostering Life Science Innovation: Part 3 – Moving University Inventions Forward
In the third part of the continuing series on the broader topic of Fostering Life Science Innovation, we zoom in on the important concept of transitioning technologies from the university lab to the next stage of...
Enhance Diagnostics Announces Leadership Transition: Dr. Matthew Leming Appointed CEO
Enhance Diagnostics, a clinical-stage company focused on non-invasive diagnostic solutions announced today a key leadership transition. Dr. Matthew Leming, PhD, formerly Chief Scientific Officer, has been appointed...
Solenic Medical Announces Successful Use of Its AMF Technology Under FDA Compassionate Use Authorization
DALLAS, Oct. 21, 2025 -- Solenic Medical, a medical device company developing an innovative treatment for orthopedic implant infections, today announced the successful, FDA-authorized compassionate use of its...
